BRISTOL-MYERS SQUIBB
Information

BRISTOL-MYERS SQUIBB

ISIN
US1101221083
Ticker
BMY
ISIN
US1101221083
Ticker
BMY
New Post

Information

large cap stock
Bristol-Myers Squibb Company is a biopharmaceutical company. The Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. It offers products for a range of therapeutic classes, which include oncology, immunology, cardiovascular and fibrosis. Its pharmaceutical products include chemically-synthesized or small molecule drugs and products produced from biological processes, called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. Its products include Revlimid, Eliquis, Opdivo, Orencia, Pomalyst/Imnovid, Sprycel, Yervoy, Abraxane, Empliciti, Reblozyl, Inrebic, Onureg, Zeposia, Vidaza, Baraclude and Breyanzi. Its products are sold to wholesalers, distributors, pharmacies, retailers, hospitals, clinics and government agencies.
Employees
30,250
Industries
Biotechnology & Drugs
Sector
Health Care

Community

Financials

52W Low
$53.22
52W High
$69.75
Market Capitalization
$143.34B
EBITDA
$20.50B
Beta
0.58311

Analyst Ratings

Target Price
$71.94
This security is covered by 21 analysts
Buy
14
Hold
7
Sell
0

Dividends

Activities

Trending